Correlation Between Merck and Verona Pharma
Can any of the company-specific risk be diversified away by investing in both Merck and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Verona Pharma PLC, you can compare the effects of market volatilities on Merck and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Verona Pharma.
Diversification Opportunities for Merck and Verona Pharma
-0.9 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Merck and Verona is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Merck i.e., Merck and Verona Pharma go up and down completely randomly.
Pair Corralation between Merck and Verona Pharma
Considering the 90-day investment horizon Merck Company is expected to under-perform the Verona Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 2.59 times less risky than Verona Pharma. The stock trades about -0.01 of its potential returns per unit of risk. The Verona Pharma PLC is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 3,367 in Verona Pharma PLC on August 30, 2024 and sell it today you would earn a total of 623.00 from holding Verona Pharma PLC or generate 18.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Verona Pharma PLC
Performance |
| Timeline |
| Merck Company |
| Verona Pharma PLC |
Merck and Verona Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Verona Pharma
The main advantage of trading using opposite Merck and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.| Merck vs. Pharvaris BV | Merck vs. Brinker International | Merck vs. Alcoa Corp | Merck vs. Direxion Daily FTSE |
| Verona Pharma vs. Ventyx Biosciences | Verona Pharma vs. Ideaya Biosciences | Verona Pharma vs. Protagonist Therapeutics | Verona Pharma vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |